Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical device company specializing in orthopedic solutions. With a ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

1 Day ZBH 1.43% DJIA 0.11% S&P 500 0.24% Health Care/Life Sciences 1.08% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

According to Benzinga Pro, Zimmer Biomet Holdings's peer group average for short interest as a percentage of float is 4.44%, which means the company has less short interest than most of its peers. Did ...

This was the stock's second consecutive day of losses.

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the ...

Atria Investments Inc boosted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 54.0% during the fourth quarter, according to its most recent Form 13F filing with the ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus rating of “Hold” from the twenty-two ...

1 Day ZBH 0.46% DJIA 1.42% S&P 500 1.76% Health Care/Life Sciences 0.13% ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...